Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methylcobalamin in Vitamin B12 Deficiency: To Give or not to Give?
Kamath A, Pemminati S. Kamath A, et al. Among authors: pemminati s. J Pharmacol Pharmacother. 2017 Jan-Mar;8(1):33-34. doi: 10.4103/jpp.JPP_173_16. J Pharmacol Pharmacother. 2017. PMID: 28405134 Free PMC article. No abstract available.
Epigenetic Mechanisms: New Targets for Heart Failure Pharmacopuncture.
Volkova YA, Opoku-Asare I, Oke LM, Pemminati S, Millis RM. Volkova YA, et al. Among authors: pemminati s. J Pharmacopuncture. 2016 Sep;19(3):195-196. doi: 10.3831/KPI.2016.19.019. J Pharmacopuncture. 2016. PMID: 27695627 Free PMC article. No abstract available.
The Current Status of New Antidiabetic Drugs.
Pemminati S, Millis RM, Kamath A, Shenoy AK, Gorantla VR. Pemminati S, et al. J Pharmacopuncture. 2016 Dec;19(4):291-292. doi: 10.3831/KPI.2016.19.029. J Pharmacopuncture. 2016. PMID: 28070450 Free PMC article. No abstract available.
Are the Newer Antidiabetic Agents Worth the Cost?
Pemminati S, Millis RM, Kamath A, Shenoy AK, Gangachannaiah S. Pemminati S, et al. J Clin Diagn Res. 2016 Mar;10(3):FL01. doi: 10.7860/JCDR/2016/17683.7384. Epub 2016 Mar 1. J Clin Diagn Res. 2016. PMID: 27134895 Free PMC article. No abstract available.
Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study.
Shivaprakash G, Udupa KS, Sarayu V, Thomas J, Gupta V, Pallavi LC, Pemminati S. Shivaprakash G, et al. Among authors: pemminati s. Indian J Pharmacol. 2017 Nov-Dec;49(6):451-457. doi: 10.4103/ijp.IJP_846_16. Indian J Pharmacol. 2017. PMID: 29674800 Free PMC article.
22 results